---
title: "AndroGel Dosing in Renal Impairment: What to Know"
description: "AndroGel 1% starts at 50 mg once daily with no renal dose change in its label. See the edema warning in kidney disease and hematocrit and PSA monitoring."
url: https://healthrx.com/androgel/renal-impairment
publisher: HealthRX.com
---


HealthRX.com

No kidney-specific dose is given in the AndroGel 1% label

[Print or save as PDF](https://healthrx.com/printables/androgel/renal-impairment?print=1)

Key numbers

- 50 mg Usual starting dose in the label, given once daily in the morning Source: [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf), as cited Oct 30, 2026
- 100 mg Highest dose the label allows, reached only by raising it when serum testosterone is low Source: [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf), as cited Oct 30, 2026
- 46% Share of men with chronic renal failure who had hypogonadism (low testosterone) Source: [pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/32395803/), as cited Oct 30, 2026
- 1.9/1.3 mm Hg Average 24-hour blood pressure rise in men given testosterone gel Source: [accessdata.fda.gov](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf), as cited Oct 30, 2026

From the public record

Registered clinical studies of testosterone in kidney impairment

ClinicalTrials.gov lists 7 registered studies that name testosterone as an intervention and list renal impairment as a condition, as of 2026-11-11. Of these, 1 are recruiting, 3 are completed and 1 are phase 3 studies.

Registered clinical studies of testosterone in kidney impairment: the figures

| Measure | Value |
| --- | --- |
| Registered studies | 7 |
| Recruiting now | 1 |
| Not yet recruiting | 0 |
| Completed | 3 |
| Terminated, withdrawn or suspended | 0 |
| Phase 3 (including phase 2/3) | 1 |
| Phase 2 (including phase 1/2) | 2 |
| Phase 1 | 0 |

Source: [NIH National Library of Medicine, ClinicalTrials.gov](https://clinicaltrials.gov/search?intr=testosterone&cond=renal%20impairment), data as of Nov 11, 2026

How this was calculated

Searched ClinicalTrials.gov for studies naming the drug as an intervention with the stated filter, downloaded every matching record and counted by status and phase. Combined phases are counted under the higher phase.

Scope: Studies whose intervention field matches testosterone and that list renal impairment as a condition, all statuses

A registered study is not a result. Counts include studies where the drug is a comparator or background treatment, and studies that never finished or reported. The filter relies on how each study was registered.

[See the public record for Testosterone](https://healthrx.com/data/testosterone)

HealthRX.com quick answer. No renal-specific dose adjustment is given for AndroGel 1%: its label says no studies were conducted in patients with renal impairment, and its dosing is a 50 mg once-daily start that can be adjusted to 75 or 100 mg by serum testosterone [1]. The same label lists edema, with or without heart failure, as a possible complication in men with preexisting kidney disease [1].

At a glance

- Renal dose adjustment / None given in the AndroGel 1% label [1]
- Starting dose, AndroGel 1% / 50 mg once daily [1]
- Dose options / 50, 75, or 100 mg daily, based on serum testosterone [1]
- Application sites / Shoulders, upper arms, and/or abdomen [1]
- Hematocrit checks / Before treatment, at 3 to 6 months, then annually [1]
- Kidney-related warning / Edema, with or without heart failure, in preexisting kidney disease [1]
- Blood pressure / Label: can increase blood pressure [1]

## Does kidney disease change the dose?

The AndroGel 1% label has a renal impairment section that says only that no studies were conducted in patients with renal impairment [1]. It contains no renal dosing table and no renal-specific [starting dose](https://healthrx.com/androgel/adult-dosing).

The label also says topical testosterone products may have different doses, strengths, or application instructions that produce different systemic exposure, and it refers to the separate 1.62% prescribing information for that product's dosing [1].

Questions worth asking

Choose the questions you want to keep Should my prescriber check me for swelling or fluid retention while I use testosterone gel? How will my testosterone levels be measured to decide whether my dose should change? Which blood tests, such as hematocrit and PSA, will I need while using testosterone gel? Will my blood pressure or diabetes medicines need review if I start testosterone gel?

## What the label says about kidney disease

**Edema.** Edema, with or without congestive heart failure, may be a complication in patients with preexisting cardiac, renal, or hepatic disease [1].

**Corticosteroids.** Testosterone with [ACTH](https://healthrx.com/labs-acth/what-it-measures) or corticosteroids may increase fluid retention, and the label calls for careful monitoring, particularly in patients with cardiac, renal, or hepatic disease [1].

**Blood pressure.** The label says AndroGel 1% can increase blood pressure. It reports an ambulatory blood pressure monitoring study in which 169 men had usable recordings at both baseline and week 16, with a mean 24-hour systolic/diastolic rise of 1.9/1.3 mm Hg; in men with hypertension already on antihypertensive therapy, the rise was 3.0/2.2 mm Hg [1]. The blood pressure section says AndroGel 1.62% is not recommended for patients with uncontrolled hypertension [1].

## Standard dosing in the AndroGel 1% label

The label says to confirm hypogonadism before starting, with morning serum testosterone measured on at least two separate days and both values below the normal range [1].

The label's starting dose is 50 mg once daily in the morning (two 25 mg packets or one 50 mg packet), applied to clean, dry, intact skin of the shoulders and upper arms and/or abdomen, not the genitals, chest, armpits, knees, or back [1]. The dose may be increased to 75 mg and then 100 mg if serum testosterone is below the normal range, and decreased if it exceeds the normal range [1].

The label says the gel is flammable until dry. Children and women should avoid contact with unwashed or unclothed application sites, and virilization has been reported in children exposed secondhand [1].

## Low testosterone is common in men with kidney failure

A cross-sectional study of 48 men with chronic renal failure, from mild to end stage, defined hypogonadism as a low (below 10 nmol/L) or low-normal (10 to 14 nmol/L) [total testosterone](https://healthrx.com/labs-total-testosterone/what-it-measures) and found it in 22 of them (46%) [2]. Gonadotropins were normal in 21 of those 22 men, hyperprolactinemia was present in 6, and [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm) and diabetic nephropathy were the only risk factors identified [2]. It is one small study, but it is a reason testosterone gets checked in this group.

## AndroGel label monitoring: hematocrit, PSA and clots

**Hematocrit.** The label calls for hematocrit before treatment, again at 3 to 6 months, then annually, and says to stop therapy if hematocrit becomes elevated until it falls to an acceptable concentration [1].

**PSA.** The label says to evaluate for prostate cancer before and during treatment [1]. In the initial 6-month study, mean PSA rose 0.26 ng/mL [1]. In a 3-year extension study of 162 men, 29 (18%) met the protocol criterion for a PSA increase (more than twice baseline or any single value above 6 ng/mL), and most did so by doubling from a low baseline [1].

**Clots.** Venous thromboembolism, including deep vein thrombosis and pulmonary embolism, has been reported with testosterone products; the label says to evaluate symptoms and to discontinue if VTE is suspected [1]. It reports that in TRAVERSE, VTE occurred in 1.7% of men on testosterone gel versus 1.2% on placebo [1].

## AndroGel drug interactions named in the label

- Corticosteroids or ACTH: increased fluid retention; careful monitoring, especially with cardiac, renal, or hepatic disease [1].
- Insulin or diabetes medicines: androgens may lower blood glucose and reduce insulin requirements [1].
- Oral anticoagulants: changes in anticoagulant activity may occur; more frequent INR and prothrombin time monitoring, especially at initiation and termination [1].

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. What is the starting dose of AndroGel 1% according to the label?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Printable lab tracker

AndroGel kidney disease monitoring tracker

Use this sheet if you have kidney disease and use AndroGel testosterone gel. Record your kidney history, bring monitoring results to your prescriber or pharmacist, and track swelling, blood pressure and lab results over time.

[Open the fill-in sheet](https://healthrx.com/printables/androgel/renal-impairment) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Is there a renal dose adjustment for testosterone gel?

The AndroGel 1% label gives none; its renal impairment section says only that no studies were conducted in these patients [1].

What is the starting dose in the AndroGel 1% label?

50 mg once daily in the morning (two 25 mg packets or one 50 mg packet), applied to clean, dry skin of the shoulders and upper arms and/or abdomen [1]. Later adjustments to 75 or 100 mg are based on serum testosterone [1].

What does the label flag for men with kidney disease on testosterone gel?

Edema, with or without congestive heart failure, as a possible complication in men with preexisting cardiac, renal, or hepatic disease [1], and increased fluid retention with ACTH or corticosteroids, requiring careful monitoring in those patients [1]. It also says AndroGel 1% can increase blood pressure [1].

Is the 1.62% gel dosed the same way?

No. The label says dosage and administration for AndroGel 1% differ from AndroGel 1.62% and refers to that product's own prescribing information [1].

How common is low testosterone in men with kidney failure?

In a cross-sectional study of 48 men with chronic renal failure, 22 (46%) had hypogonadism, defined as low (below 10 nmol/L) or low-normal (10 to 14 nmol/L) total testosterone [2]. Gonadotropins were normal in 21 of those 22 men and hyperprolactinemia was present in 6 [2].

References

Show all 2 references Hide references

1. U.S. Food and Drug Administration, Drugs@FDA. AndroGel (testosterone gel) 1% prescribing information, NDA 021015, supplement 047, July 2025. [AndroGel 1% prescribing information](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021015s047lbl.pdf)
2. Oueslati I, Ounissi M, Talbi E, Azaiez S, Bacha MM, Ben Abdallah T. [Prevalence and risk factors of hypogonadism in men with chronic renal failure](https://pubmed.ncbi.nlm.nih.gov/32395803/). Tunis Med. 2020;98(2):138-143.

Next in this cluster

Related reading

- [testosterone AndroGel hepatic impairment](https://healthrx.com/androgel/hepatic-impairment)
- [testosterone AndroGel pharmacokinetics](https://healthrx.com/androgel/pharmacokinetics)
- [testosterone AndroGel how to safely stop](https://healthrx.com/androgel/discontinuation-protocol)
- [testosterone AndroGel cost](https://healthrx.com/androgel/cost-vs-alternatives)
- [testosterone AndroGel Safety Signals and FDA Actions](https://healthrx.com/androgel/safety-signals-fda)
- [testosterone AndroGel seasonal use](https://healthrx.com/androgel/seasonal-considerations)
- [testosterone AndroGel Sexual Function Impact](https://healthrx.com/androgel/sexual-function-impact)
- [testosterone AndroGel special populations](https://healthrx.com/androgel/special-populations)
- [testosterone AndroGel storage](https://healthrx.com/androgel/storage-stability)
- [testosterone AndroGel Switching](https://healthrx.com/androgel/switching-protocols)
- [testosterone AndroGel travel protocol](https://healthrx.com/androgel/travel-protocols)
- [testosterone Does TRICARE cover AndroGel](https://healthrx.com/androgel/tricare-coverage)
- [testosterone androgel Testosterone gel](https://healthrx.com/mens-trt/testosterone-gel-androgel)
- [testosterone AndroGel alcohol](https://healthrx.com/lifestyle-androgel/alcohol)

![androgel renal impairment: physician reviewing kidney health with an older male patient in a clinic](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/androgel/renal-impairment.webp)

The label offers no kidney-specific dose adjustment, so clinicians and patients review kidney function and swelling risk together during visits. Full AndroGel dosing renal impairment guide and sources at [healthrx.com/androgel](https://healthrx.com/androgel).
